Ranbaxy’s Q4 net up 323%

Ranbaxy Laboratories Ltd on Thursday announced a whopping 323 per cent growth in profit after tax (PAT) to Rs 212.70 crore for the fourth qu...

Ranbaxy Laboratories Ltd on Thursday announced a whopping 323 per cent growth in profit after tax (PAT) to Rs 212.70 crore for the fourth quarter ended December 2002 from Rs 50.30 crore in the corresponding quarter of 2001.

Sales rose 42.10 per cent to Rs 808.80 crore from Rs 569 crore.For the full year 2002, PAT was up 139 per cent to Rs 605.40 crore from Rs 253.30 crore in the previous year while sales rose 40 per cent to Rs 2,880.50 crore from Rs 2054.50 crore in 2001.

Export sales were up 78 per cent to Rs 1835.60 crore from Rs 1029.10 crore. Profit before extra-ordinary items and tax shot up to Rs 645.50 crore from Rs 241.30 crore, a growth of 168 per cent. Earning per share on a fully diluted basis was Rs 32.59 ( Rs 13.64)

Consolidated global sales (Ranbaxy Labs and subsidiaries) for the fourth quarter stood at Rs 1,091.30 crore ($225 million) and for the year 2002 at Rs 3,832 crore ($789 million). Net consolidated sales were Rs 1058.90 crore ($218 million) during the fourth quarter and Rs 3711.30 crore ($764 million) during the full year 2002.

Debris found in Dal Lake could be from missile Pak fired during Op Sindoor

India2 hr ago

Debris believed to be from a missile fired by Pakistan during Operation Sindoor in May has been found in Srinagar's Dal Lake. The debris has been handed over to the Air Force for further investigation. Sources say the target may have been a military installation in Srinagar, which is close to the lake. The make of the missile is yet to be determined.

View all shorts

Live Blog